(Q44648728)

English

Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction

scientific article published on November 5, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

ventricular remodeling

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Johann Bauersachs

6

object named as

Johann Bauersachs

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Daniela Fraccarollo

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Paolo Galuppo

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Steven Hildemann

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Michael Christ

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Georg Ertl

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5 November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607457

30 March 2024

full work available at URL

https://doi.org/10.1016/j.jacc.2003.05.003

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607457

30 March 2024

https://api.elsevier.com/content/article/PII:S0735109703010805?httpAccept=text/xml

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

https://api.elsevier.com/content/article/PII:S0735109703010805?httpAccept=text/plain

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1666-1673

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.1038/21224

15 July 2023

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

2

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

3

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Aldosterone production is activated in failing ventricle in humans

4

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

5

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

6

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy

7

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

8

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Aldosterone in congestive heart failure

9

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure

10

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression

11

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

12

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.

13

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Effect of a selective aldosterone receptor antagonist in myocardial infarction

14

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

15

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

16

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

17

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

18

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

19

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Aldosterone induces a vascular inflammatory phenotype in the rat heart

20

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Hemodynamic determinants of the time-course of fall in canine left ventricular pressure

21

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Left ventricular volumetric conductance catheter for rats

22

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

23

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Matrix metalloproteinases: regulation and dysregulation in the failing heart

24

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis

25

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism

26

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats

27

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.

28

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor

29

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Cardiac aldosterone production in genetically hypertensive rats

30

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

31

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.

32

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients

33

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Is tau a preload-independent measure of isovolumetric relaxation?

34

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Load independence of the rate of isovolumic relaxation in man

35

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Alterations of calcium-regulatory proteins in heart failure

36

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure

37

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

38

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.

40

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure

41

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.

42

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Mineralocorticoid receptor antagonism in experimental atherosclerosis

43

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading

44

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy

45

1 reference

10.1016/J.JACC.2003.05.003

https://api.crossref.org/works/10.1016/J.JACC.2003.05.003

30 March 2024

Identifiers

10.1016/J.JACC.2003.05.003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44648728&oldid=2114365039"